MedTrace Logo

Observational Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Techniques in Spain.

NCT02941341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1222

Last updated 2020-02-05

No results posted yet for this study

Summary

Non-comparative, observational, ambispective post-authorisation study (EPA-SP).

Conditions

Interventions

DRUG

r-hFSH

As per standard practice

Sponsors & Collaborators

  • Finox AG

    lead INDUSTRY

Principal Investigators

  • Marcos Ferrando, MD · Director IVI Bilbao, Spain

  • Buenaventura Coroleu Lletget, MD · Jefe del Servicio de Medicina de la Reproducción,Hospital Universitari Quirón Dexeus, Barcelona, Spain

  • Luis Rodríguez-Tabernero Martín, MD · Jefe de la Unidad de Reproducción, Hospital Clínico Universitario de Valladolid, Valladolid, Spai^n

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-04-30
Completion
2019-04-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02941341 on ClinicalTrials.gov